Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
Warby ParkerWRBY 69 Receivables Turnover is 122.63 as of Jun. 2026. GuruFocus rates WRBY with a GF Score™ of 69/100 and a GF Value™ of $21.61 (Modestly Overvalued). The stock has 4 warning signs investors should review. Among 813 Medical Devices & Instruments companies, Warby Parker ranks better than 99.88% on this metric.
The Receivables Turnover ratio measures the number of times a company collects its average accounts receivable balance. It is calculated as Revenue divided by average Accounts Receivable. An efficient company has a higher accounts receivable turnover ratio while an inefficient company has a lower ratio. Warby Parker's Revenue for the
three
months ended in Jun. 2026 was $235.5 Mil. Warby Parker's average Accounts Receivable for the
three
months ended in Jun. 2026 was $1.9 Mil.
Hence, Warby Parker's Receivables Turnover for the
three
months ended in Jun. 2026 was 122.63.
An efficient company has a higher accounts receivable turnover ratio while an inefficient company has a lower ratio. This metric is commonly used to compare companies within the same industry to check whether they are on par with their competitors.
Warby Parker Receivables Turnover Related Terms
Warby Parker Receivables Turnover Historical Data
* Premium members only.
The historical data trend for Warby Parker's Receivables Turnover can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
WRBY vs XRAY, LMAT, PLSE: Receivables Turnover Comparison
For the Medical Instruments & Supplies subindustry, Warby Parker's Receivables Turnover, along with its competitors' market caps and Receivables Turnover data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Warby Parker Receivables Turnover vs Medical Devices & Instruments Industry
For the Medical Devices & Instruments industry and Healthcare sector, Warby Parker's Receivables Turnover distribution charts can be found below:
* The bar in red indicates where Warby Parker's Receivables Turnover falls into.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Warby Parker (WRBY) has a Receivables Turnover of 122.63 as of Jun. 2026. The accounts receivables turnover ratio measures the number of times a company collects its average accounts receivable balance. It is calculated as Revenue divided by Average Accounts Receivable. View historical data on Warby Parker and its competitors. According to the industry distribution chart, Warby Parker ranks #1 out of 813 companies in the Medical Devices & Instruments industry, placing it in the top 0.099999999999994%.
Is Warby Parker's Receivables Turnover too high?
Warby Parker's current Receivables Turnover is 122.63. The Medical Devices & Instruments industry median Receivables Turnover is 5.60. Warby Parker's value of 122.63 is 2089.8% above this industry median. Based on the distribution chart, Warby Parker ranks #1 out of 813 companies in the Medical Devices & Instruments industry, which is in the top quartile — a strong position relative to peers. Overall, Warby Parker has a GF Score™ of 69/100 and is considered Modestly Overvalued, reflecting its overall financial health beyond just this single metric.
How does Warby Parker's Receivables Turnover compare to XRAY and LMAT?
According to the Medical Devices & Instruments industry distribution chart, Warby Parker ranks #1 out of 813 companies for Receivables Turnover. This places Warby Parker in the top 0% of its industry — outperforming the majority of peers. The industry median Receivables Turnover is 5.60. Warby Parker's value of 122.63 is 2089.8% above this benchmark. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Receivables Turnover for a Medical Devices & Instruments company?
The median Receivables Turnover among Medical Devices & Instruments companies is 5.60, based on 813 companies in the industry. Companies in the top quartile (top 25%) have a Receivables Turnover significantly above this median, while those in the bottom quartile fall well below. However, Receivables Turnover should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Warby Parker's current Receivables Turnover of 122.63 is 2089.8% above the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Receivables Turnover mean?
A high Receivables Turnover can signal that a stock is expensive relative to its fundamentals. The accounts receivables turnover ratio measures the number of times a company collects its average accounts receivable balance. It is calculated as Revenue divided by Average Accounts Receivable. View historical data on Warby Parker and its competitors. For the Medical Devices & Instruments industry, the median Receivables Turnover is 5.60 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Warby Parker's current Receivables Turnover is 122.63. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Warby Parker stock overvalued right now?
Based on GuruFocus' analysis, Warby Parker (WRBY) is currently considered Modestly Overvalued. The stock's GF Value™ is $21.61, compared to a current price of $26.41 — trading 22.2% above its estimated fair value. The current Receivables Turnover is 122.63 and 2089.8% above the Medical Devices & Instruments industry median of 5.60. Warby Parker's overall GF Score™ is 69/100 with 4 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Receivables Turnover calculated?
Receivables Turnover is calculated from a company's financial statements. For Warby Parker (WRBY), the current Receivables Turnover is 122.63 as of Jun. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Warby Parker (WRBY) Overvalued in 2026?
Based on GuruFocus' analysis, Warby Parker stock appears to be overvalued.
The current stock price of $26.41 is trading 22.2% above its estimated GF Value™ of $21.61.
GuruFocus considers Warby Parker to be Modestly Overvalued.
Key valuation signals for WRBY:
Receivables Turnover: 122.63
GF Value™: $21.61 vs. price of $26.41 (22.2% above fair value)
Industry Position: 2089.8% above the Medical Devices & Instruments median (#1 of 813)
No single metric tells the full story. See the WRBY stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Warby Parker Inc is a mission-driven, lifestyle brand that operates at the intersection of design, technology, healthcare, and social enterprise. The Company provides holistic vision care by offering eyewear, contacts, and eye care directly to consumers through its integrated, omnichannel platform. The company predominantly derives revenue from the sales of eyewear products, optical services, and accessories. The firm sells products and services through its stores, website, and mobile apps. Revenue generated from eyewear products includes the sales of prescription and non-prescription optical glasses and sunglasses, contact lenses, eyewear accessories, and expedited shipping charges.
69GF Score
Get the complete analysis for WRBY
Receivables Turnover is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
WRBY has been successfully added to your 
